Search research articles
Contact Us
Filters
Showing results (1-10 of 32) with videos related to
Page
of 4
Sort By:
Drug Discovery Today
|
January 16, 2002
Routine cognitive testing for all drugs?
John E Harrison
Alzheimer'S & Dementia (Amsterdam, Netherlands)
|
February 1, 2021
Commentary: Composite cognitive and functional measures for early stage Alzheimer's disease trials
John E Harrison
CNS Spectrums
|
March 13, 2019
Screening and measurement of cognitive impairment in psychiatry
John E Harrison
Alzheimer'S Research & Therapy
|
July 1, 2018
Cognition comes of age: comments on the new FDA draft guidance for early Alzheimer's disease
John E Harrison
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association
|
December 25, 2025
Drug Development
John E Harrison
Dialogues in Clinical Neuroscience
|
October 29, 2011
The evaluation of cognitive function in the dementias: methodological and regulatory considerations
Keith A Wesnes, John E Harrison
International Journal of Methods in Psychiatric Research
|
June 24, 2022
Further validation of the THINC-it tool and extension of the normative data set in a study of n = 10.019 typical controls
Maria Dalby, Peter Annas, , et al.
The International Journal of Neuropsychopharmacology
|
May 28, 2016
Which Cognitive Domains are Improved by Treatment with Vortioxetine?
John E Harrison, Søren Lophaven, Christina K Olsen
Alzheimer'S & Dementia (New York, N. Y.)
|
October 26, 2019
FDA position statement "Early Alzheimer's disease: Developing drugs for treatment, Guidance for Industry"
Marwan N Sabbagh, Suzanne Hendrix, John E Harrison
Alzheimer'S Research & Therapy
|
February 13, 2016
Alzheimer's Disease Assessment Scale-Cognitive subscale variants in mild cognitive impairment and mild Alzheimer's disease: change over time and the effect of enrichment strategies
Jana Podhorna, Tillmann Krahnke, Michael Shear, et al.
Page
of 4
Search research articles
Search
Showing results (1-10 of 32) with videos related to
Sort By:
Page
of 4
Drug Discovery Today
|
January 16, 2002
Routine cognitive testing for all drugs?
John E Harrison
Alzheimer'S & Dementia (Amsterdam, Netherlands)
|
February 1, 2021
Commentary: Composite cognitive and functional measures for early stage Alzheimer's disease trials
John E Harrison
CNS Spectrums
|
March 13, 2019
Screening and measurement of cognitive impairment in psychiatry
John E Harrison
Alzheimer'S Research & Therapy
|
July 1, 2018
Cognition comes of age: comments on the new FDA draft guidance for early Alzheimer's disease
John E Harrison
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association
|
December 25, 2025
Drug Development
John E Harrison
Dialogues in Clinical Neuroscience
|
October 29, 2011
The evaluation of cognitive function in the dementias: methodological and regulatory considerations
Keith A Wesnes, John E Harrison
International Journal of Methods in Psychiatric Research
|
June 24, 2022
Further validation of the THINC-it tool and extension of the normative data set in a study of n = 10.019 typical controls
Maria Dalby, Peter Annas, , et al.
The International Journal of Neuropsychopharmacology
|
May 28, 2016
Which Cognitive Domains are Improved by Treatment with Vortioxetine?
John E Harrison, Søren Lophaven, Christina K Olsen
Alzheimer'S & Dementia (New York, N. Y.)
|
October 26, 2019
FDA position statement "Early Alzheimer's disease: Developing drugs for treatment, Guidance for Industry"
Marwan N Sabbagh, Suzanne Hendrix, John E Harrison
Alzheimer'S Research & Therapy
|
February 13, 2016
Alzheimer's Disease Assessment Scale-Cognitive subscale variants in mild cognitive impairment and mild Alzheimer's disease: change over time and the effect of enrichment strategies
Jana Podhorna, Tillmann Krahnke, Michael Shear, et al.
Page
of 4